-
November 11, 2016 Lupin Launches Novel Injectable Iron Formulation Under Brand Names “ISOFER” and “JILAZO” in India
-
November 9, 2016 Lupin’s Quarter II, FY2017 – Results
-
November 4, 2016 Lupin receives EIR from US FDA for Goa, March 2016 Inspection
-
November 1, 2016 Lupin Receives FDA Approval for Generic Ortho-Cyclen® 28 Tablets
-
October 13, 2016 Type 2 Diabetes: Boehringer Ingelheim India and Lupin Announce Strategic Co-marketing Agreement
-
October 6, 2016 Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products
-
September 29, 2016 Lupin Receives FDA Approval for Generic Namenda XR® Capsules
-
September 6, 2016 Lupin Receives Tentative Approval for Generic Rapaflo® Capsules
-
September 1, 2016 Lupin Receives Tentative Approval for Generic Zithromax® Oral Suspension
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications